|
AFTPH expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.86206605690131E-12 |
| Normal-vs-Stage2 |
3.685000E-03 |
| Normal-vs-Stage3 |
1.62470037423645E-12 |
| Normal-vs-Stage4 |
4.77395900588817E-15 |
| Stage1-vs-Stage2 |
6.687800E-01 |
| Stage1-vs-Stage3 |
2.860200E-03 |
| Stage1-vs-Stage4 |
6.642500E-04 |
| Stage2-vs-Stage3 |
5.640400E-02 |
| Stage2-vs-Stage4 |
2.268100E-02 |
| Stage3-vs-Stage4 |
4.752000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.62714286489063E-12 |
| Normal-vs-Asian |
8.851600E-02 |
| Caucasian-vs-AfricanAmerican |
3.725800E-02 |
| Caucasian-vs-Asian |
8.377400E-01 |
| AfricanAmerican-vs-Asian |
2.847000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
3.8386000000834E-07 |
| Male-vs-Female |
7.99730000000665E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.64590563400679E-12 |
| Normal-vs-Age(41-60Yrs) |
6.09956529729061E-13 |
| Normal-vs-Age(61-80Yrs) |
4.44089209850063E-16 |
| Normal-vs-Age(81-100Yrs) |
2.644100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.715420E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.220800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.904300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.691400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.587200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.451800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.035000E-04 |
| Normal-vs-Grade 2 |
8.99530006037708E-10 |
| Normal-vs-Grade 3 |
1.54321000422897E-14 |
| Normal-vs-Grade 4 |
<1E-12 |
| Grade 1-vs-Grade 2 |
9.167600E-01 |
| Grade 1-vs-Grade 3 |
1.992650E-01 |
| Grade 1-vs-Grade 4 |
1.563100E-03 |
| Grade 2-vs-Grade 3 |
5.288500E-02 |
| Grade 2-vs-Grade 4 |
3.26359994584635E-09 |
| Grade 3-vs-Grade 4 |
2.17499999999315E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.042200E-02 |
| Normal-vs-ccB subtype |
<1E-12 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.76134670684769E-12 |
| Normal-vs-N1 |
2.52160003988422E-09 |
| N0-vs-N1 |
1.872040E-01 |
|
|
